About Praxis Fuer Internistische Haematologie / Onkologie
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
German High-Grade Non-Hodgkin's Lymphoma Study Group
2
iOMEDICO AG
2
Daiichi Sankyo, Inc.
1
Elevation Oncology
1
Heinrich-Heine University, Duesseldorf
1
Hoffmann-La Roche
1
III. Medizinische Klinik Mannheim
1
University Hospital, Basel, Switzerland
1
Clinical Trials at Praxis Fuer Internistische Haematologie / Onkologie
During the past decade, Praxis Fuer Internistische Haematologie / Onkologie conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on
average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia
Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer (TAXIS)
Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic NSCLC / Extensive-stage SCLC / Advanced TNBC Under First-line Treatment With Atezolizumab Plus Chemotherapy
2019-07-10
2021-07-01
Completed
154
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Praxis Fuer Internistische Haematologie / Onkologie" #1 sponsor was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 2 trials, followed by "iOMEDICO AG" with 2 trials
sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored, "Elevation Oncology" with 1 trials sponsored and "Heinrich-Heine University, Duesseldorf"
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Praxis Fuer Internistische Haematologie / Onkologie"
#1 collaborator was "Roche Pharma AG" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Austrian Breast Cancer Study Group" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 9 trials.
Clinical Trials Conditions at Praxis Fuer Internistische Haematologie / Onkologie
According to Clinical.Site data, the most researched conditions in "Praxis Fuer Internistische Haematologie / Onkologie" are
"Leukemia" (2 trials), "Lymphoma" (2 trials), "Advanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBC" (1 trials), "Advanced Solid Tumors or Hematologic Malignancies" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Praxis Fuer Internistische Haematologie / Onkologie" in a lesser frequency.
Most popular intervention types in "Praxis Fuer Internistische Haematologie / Onkologie" are "Drug" (7 trials), "Biological" (4 trials), "Radiation" (4 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "cyclophosphamide" (4 trials), "doxorubicin hydrochloride" (3 trials), "radiation therapy" (3 trials), "filgrastim" (2 trials) and "prednisone" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Praxis Fuer Internistische Haematologie / Onkologie
The vast majority of trials in "Praxis Fuer Internistische Haematologie / Onkologie" are
8 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Praxis Fuer Internistische Haematologie / Onkologie
Currently, there are NaN active trials in "Praxis Fuer Internistische Haematologie / Onkologie".
undefined are not yet recruiting,
3 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Praxis Fuer Internistische Haematologie / Onkologie,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Praxis Fuer Internistische Haematologie / Onkologie, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".
Departments of Praxis Fuer Internistische Haematologie / Onkologie
Praxis Fuer Internistische Haematologie / Onkologie has several departments that took part in Clinical trials: "Dres. Helmut Forstbauer, Carsten Ziske und Kollegen; Onkologische Schwerpunktpraxis" - 4 trials